相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice
Sara A. Healy et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
A human monoclonal antibody blocks malaria transmission and defines a highly conserved neutralizing epitope on gametes
Camila H. Coelho et al.
NATURE COMMUNICATIONS (2021)
Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment
Wei-Chiao Huang et al.
NPJ VACCINES (2020)
Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins
Kavita Singh et al.
COMMUNICATIONS BIOLOGY (2020)
Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
Wei-Chiao Huang et al.
MALARIA JOURNAL (2020)
Identification of domains within Pfs230 that elicit transmission blocking antibody responses
Mayumi Tachibana et al.
VACCINE (2019)
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
Susheel K. Singh et al.
FRONTIERS IN IMMUNOLOGY (2019)
Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230
Puthupparampil Scaria et al.
NPJ VACCINES (2019)
Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity
Jo-Anne Chan et al.
PLOS ONE (2019)
Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha
David Wetzel et al.
PLOS ONE (2019)
Expression and purification optimization of an N-terminal Pfs230 transmission-blocking vaccine candidate
Shwu-Maan Lee et al.
PROTEIN EXPRESSION AND PURIFICATION (2019)
The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
Shwu-Maan Lee et al.
MALARIA JOURNAL (2019)
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults
Issaka Sagara et al.
LANCET INFECTIOUS DISEASES (2018)
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity
Puthupparampil V. Scaria et al.
PLOS ONE (2017)
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
Stephen W. Scally et al.
NATURE COMMUNICATIONS (2017)
Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230
Nicholas J. MacDonald et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Safety and Immunogenicityof Pfs25-EPA/Alhydrogel® , a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naive Adults
Kawsar R. Talaat et al.
PLOS ONE (2016)
Heat-precipitation allows the efficient purification of a functional plant-derived malaria transmission-blocking vaccine candidate fusion protein
Veronique Beiss et al.
BIOTECHNOLOGY AND BIOENGINEERING (2015)
Comparative Assessment of Transmission-Blocking Vaccine Candidates against Plasmodium falciparum
M. C. Kapulu et al.
SCIENTIFIC REPORTS (2015)
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
Richard L. Shimp et al.
VACCINE (2013)
N-Terminal Prodomain of Pfs230 Synthesized Using a Cell-Free System Is Sufficient To Induce Complement-Dependent Malaria Transmission-Blocking Activity
Mayumi Tachibana et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum
Christine E. Farrance et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines
Vu Dinh Thiem et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children
Justen H. Passwell et al.
VACCINE (2010)
Malaria transmission-blocking antigen, Pfs230, mediates human red blood cell binding to exflagellating male parasites and oocyst production
Saliha Eksi et al.
MOLECULAR MICROBIOLOGY (2006)
Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum
DL Gerloff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children
FYC Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
